Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles
Top Cited Papers
Open Access
- 10 June 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 25 (8), 2092-2100
- https://doi.org/10.1093/humrep/deq125
Abstract
The influence of elevated serum progesterone levels during in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) cycles on pregnancy rates is a matter of continued debate among fertility clinicians. Efforts to resolve this question have been impeded by the various assays used to measure progesterone and the different, arbitrary threshold values for defining ‘high’ progesterone levels. A non-interventional, retrospective, observational, single-centre cohort study evaluated the relationship between serum progesterone levels on the day of human chorionic gonadotrophin (hCG) administration and the ongoing pregnancy rate in 4032 patients undergoing IVF/ICSI cycles using gonadotrophin-releasing hormone (GnRH) analogues for pituitary down-regulation. Ongoing pregnancy rates were inversely associated with serum progesterone levels on the day of hCG (P < 0.001 for overall trend), irrespective of the GnRH analogue used for pituitary down-regulation. Patients with serum progesterone levels ≤1.5 ng/ml had significantly higher ongoing pregnancy rates than those with progesterone levels >1.5 ng/ml (31.0 versus 19.1%; P = 0.00006); odds ratio, 0.53 (95% confidence interval, 0.38–0.72). Multivariate regression analysis showed that daily follicle-stimulating hormone dose, number of oocytes and estradiol values on the day of hCG administration were positively associated with progesterone levels (P < 0.0001 for all). Serum progesterone levels were significantly greater in women treated with GnRH agonists (n = 1177) versus antagonists (n = 2855; 0.84 ± 0.67 versus 0.75 ± 0.66 ng/ml; P = 0.0003). Elevated serum progesterone levels on the day of hCG administration is associated with reduced ongoing pregnancy rates. In particular, serum progesterone levels of >1.5 ng/ml were associated with lower ongoing pregnancy rates following IVF/ICSI cycles irrespective of the GnRH analogue used for pituitary down-regulation.Keywords
This publication has 43 references indexed in Scilit:
- Highly purified hMG achieves better pregnancy rates in IVF cycles but not ICSI cycles compared with recombinant FSH: a meta-analysisGynecological Endocrinology, 2009
- Highly purified hMG versus recombinant FSH in ovarian hyperstimulation with GnRH antagonists--a randomized studyHuman Reproduction, 2008
- Comment on: is progesterone elevation on the day of human chorionic gonadotrophin administration associated with the probability of pregnancy in in vitro fertilization? A systematic review and meta-analysis. By Venetis et al (2007).Human Reproduction Update, 2008
- Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trialHuman Reproduction, 2006
- Serum luteinizing hormone in patients undergoing ovarian stimulation with gonadotropin-releasing hormone antagonists and recombinant follicle-stimulating hormone and its relationship with cycle outcomeFertility and Sterility, 2005
- Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcomeFertility and Sterility, 2003
- The endometrium in stimulated cycles for IVFHuman Reproduction Update, 2003
- Luteinizing Hormone Increases Estradiol Secretion but has no Effect on Progesterone Concentrations in the Late Follicular Phase of In Vitro Fertilization Cycles in Women Treated with Gonadotropin-Releasing Hormone Agonist and Follicle-Stimulating HormoneFertility and Sterility, 1998
- Elevated progesterone levels in the late follicular phase do not predict success of in vitro fertilization-embryo transferFertility and Sterility, 1996
- Predictive Value of Serum Progesterone Levels for Pregnancy Outcome?Fertility and Sterility, 1994